| ¿µ¹® | anaphylaxis | ÇÑ±Û | ¾Æ³ªÇʶô½Ã½º, °ú¹ÎÁõ |
|---|---|---|---|
| ¼³¸í | ¾Æ³ªÇʶô½Ã½º¶ó´Â ¸»Àº Á¦ 1Çü °ú¹Î¹ÝÀÀ°ú °°Àº ¸»·Î ¿Ü°èÀÇ ¹°Áú¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀÀÌ Áö³ªÄ¡°Ô Ç×ÁøµÇ¾î ÀÖ´Â º´ÀûÀÎ »óŸ¦ ¸»ÇÑ´Ù. ¸é¿ªÀ̶õ ¿ÜºÎ¹°Áú¿¡ ´ëÇÑ ¹æ¾î¸¦ ¸ñÀûÀ¸·Î ÇÏ´Â ¼¼Æ÷µéÀÇ È°µ¿À» ÀǹÌÇϸç, ¿©±â¿¡´Â Ç×üÀÇ Çü¼º, ¼¼Æ÷µéÀÇ Æ÷½ÄÀÛ¿ë(¿ÜºÎ¿¡¼ µé¾î¿Â ¹°ÁúÀ» ¸é¿ª±â´ÉÀ» ÇÏ´Â ¼¼Æ÷°¡ Àâ¾Æ¸Ô´Â °Í)µîÀÌ Æ÷ÇԵȴÙ. Ç×üÀÇ Çü¼ºÀº ¿ÜºÎ·ÎºÎÅÍ µé¾î¿Â ¹°ÁúÀ» ¿ì¼± Å«Æ÷½Ä¼¼Æ÷ µîÀÌ Æ÷½ÄÀ» Çϰí À̰Ϳ¡ ´ëÇÑ Á¤º¸¸¦ T-¸²ÇÁ±¸¿¡°Ô Àü´ÞÇϰí T-¸²ÇÁ±¸´Â ÀÌ Á¤º¸¸¦ ó¸®ÇÏ¿© Áý¾àµÈ Á¤º¸¸¦ B-¸²ÇÁ±¸¿¡°Ô Àü´ÞÇϸç ÀÌ ¼¼Æ÷·Î ÇÏ¿©±Ý ±× ¹°Áú ¿¡ ´ëÇÑ Ç×ü¸¦ »ý¼ºÇÏ°Ô ÇÑ´Ù. Ç×ü´Â ¿ÜºÎÀÇ ¹°Áú°ú Á¤È®È÷ °áÇÕÇÏ¿© ¿ÜºÎÀÇ ¹°ÁúÀÇ È°¼ºÈ¸¦ ¾ø¾Ö´Â ¹°ÁúÀÌ´Ù. ÀÌ·¸°Ô Çü¼ºµÈ Ç×üÁß¿¡¼ IgE¿¡ ºÎÂøµÉ ¼ö ÀÖ´Â, Áï ÀÌ¹Ì Ç×ü IgE°¡ Çü¼ºµÈ(ÀÌ·¸°Ô µÇ±â À§Çؼ´Â ±× ¹°ÁúÀÌ ÀÌÀü¿¡ ÇÑ ¹ø ¸ö¼Ó¿¡ µé¾î ¿Ô¾î¾ß ÇÑ´Ù) ¹°ÁúÀÌ È÷½ºÅ¸¹Î µîÀÇ ¿©·¯ ¹°ÁúÀÌ ³ª¿À°Ô µÇ°í ÀÌ·± ¹°Áúµé¿¡ ÀÇÇØ¼ »ý±â´Â ¿©·¯ °¡Áö ½Åü¿¡ ÇØ·Î¿î ¹ÝÀÀÀÌ »ý°Ü³´Ù. ±×·¡¼ ÇÊ¿ä ÀÌ»óÀ¸·Î °ú¹ÎÇÑ ÀÌ·¯ÇÑ ÇüÅÂÀÇ ¸é¿ªÀÛ¿ëÀ» °ÅÄ¡´Â ¹ÝÀÀÀ» ¾Æ´ÏÇʶô½Ã½º¶ó ÇÑ´Ù. |
||
| SRS-A | Slow Reacting Substance of Anaphylaxis |
|---|---|
| ASA | acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes... |
| BK-A | basophil kallikrein of anaphylaxis |
| ECFA, ECF-A | eosinophilic chemotactic factor of anaphylaxis |
| PAF-A | platelet-activating factor of anaphylaxis |
| A/S | antiserum |
|---|---|
| ACA | Active cutaneous anaphylaxis |
| IA | Idiopathic Anaphylaxis |
| PCA | Passive Cutaneous Anaphylaxis |
| SRS-A | Slow Reacting Substance of Anaphylaxis |
| antiserum anaphylaxis | A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations. Synonym: antiserum anaphylaxis. (05 Mar 2000) |
|---|
| antiserum | <haematology, immunology> Serum containing immunoglobulins against specified antigens. (13 Jan 1998) |
|---|---|
| monovalent antiserum | See: antiserum. (05 Mar 2000) |
| polyclonal antiserum | A mixture of antibodies to a variety of antigens or to a variety of determinants on a single antigen. (09 Oct 1997) |
| polyvalent antiserum | See: antiserum. (05 Mar 2000) |
| heterologous antiserum | An antiserum that reacts with (e.g., agglutinates) certain microorganisms or other complexes of antigens, even though the antiserum was produced by means of stimulation with a different microorganism or antigenic material. See: homologous antiserum. (05 Mar 2000) |
| homologous antiserum | An antiserum in which there is complete correspondence between the content of antibodies and the antigenic material used for producing the antiserum. (05 Mar 2000) |
| specific antiserum | See: antiserum. (05 Mar 2000) |
| nerve growth factor antiserum | An antiserum containing antibodies against nerve growth factor; when injected into newborn animals the majority of sympathetic ganglion cells are permanently destroyed, resulting in hypoinnervation of peripheral tissues. Synonym: NGF antiserum. (05 Mar 2000) |
| NGF antiserum | An antiserum containing antibodies against nerve growth factor; when injected into newborn animals the majority of sympathetic ganglion cells are permanently destroyed, resulting in hypoinnervation of peripheral tissues. Synonym: NGF antiserum. (05 Mar 2000) |
| active anaphylaxis | Reaction following inoculation of antigen in a subject previously sensitised to the specific antigen, in contrast to passive anaphylaxis. (05 Mar 2000) |
| aggregate anaphylaxis | <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism. <immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses. Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension. See: hypersensitivity. (18 Nov 1997) |
| anaphylaxis | <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism. <immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses. Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension. See: hypersensitivity. (18 Nov 1997) |
| generalised anaphylaxis | The immediate response, involving smooth muscles and capillaries throughout the body of a sensitised individual, that follows intravenous (and occasionally intracutaneous) injection of antigen (allergen). See: anaphylactic shock. Synonym: systemic anaphylaxis. (05 Mar 2000) |
| passive anaphylaxis | A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations. Synonym: antiserum anaphylaxis. (05 Mar 2000) |
| passive cutaneous anaphylaxis | An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. Pca is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|